USFDA concludes cGMP inspection at analytical testing facility of Cipla’s arm

21 Feb 2025 Evaluate

United States Food and Drugs Administration (USFDA) has concluded a current Good Manufacturing Practices (cGMP) inspection at Cipla’s wholly owned subsidiary -- Sitec Labs’ (Sitec) analytical testing facility located in Mahape, Navi Mumbai. The inspection conducted from February 18, 2025 to February 20, 2025.

On conclusion of the inspection, Sitec received two observations in Form 483. The Company will work closely with the USFDA and remains committed to address these observations comprehensively within stipulated time.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1520.55 -0.65 (-0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×